ArticleMedical science monitor : international medical journal of experimental and clinical research2018
Antimicrobial Resistance Profiles of Nosocomial Pathogens in Regional China: A Brief Report from Two Tertiary Hospitals in China.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Antimicrobial Peptides as Next-Generation Disinfectants: Tackling Biocide and Antimicrobial Resistance in Hospital Hygiene - A Narrative Review.Probiotics and antimicrobial proteins · 2026Review
- Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions.Frontiers in microbiology · 2025Review
- Article
- Potentially Virulent Multi-Drug ResistantDiagnostics (Basel, Switzerland) · 2023Article
- Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: Results from CARVIS-NET program.Frontiers in microbiology · 2022Article
- Antimicrobial stewardship and infection prevention interventions targeting healthcare-associatedBMJ open · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Antimicrobial resistance of nosocomial pathogens has become a worldwide problem that leads to major healthcare and economic burdens. Regional antimicrobial resistance profiles are needed to inform selection of proper antimicrobial agents. MATERIAL AND METHODS In collaboration with the Hospital Infection Control Office at our hospitals, we analyzed the constitution of nosocomial pathogens and the corresponding drug-resistance profiles. We paid particular attention to characteristics of pathogens that were derived from the bloodstream, and summarized the drug-resistance tendency of 2 specific bacteria within the most recent decade to reflect the development of resistance in regional China. RESULTS The most common types of nosocomial pathogens were Escherichia coli (859 isolates, 14.3%), Staphylococcus aureus (763 isolates, 12.7%), Acinetobacter baumannii (681 isolates, 11.3%), Klebsiella pneumonia (660 isolates, 11.0%), and Pseudomonas aeruginosa (654 isolates, 10.9%). The most common types of bloodstream-derived pathogens were K. pneumoniae (125 isolates, 16.3%), E. coli (118 isolates, 15.3%), A. baumanii (81 isolates, 10.5%), Candida albians (57 isolates, 7.4%), S. aureus (45 isolates, 5.9%), P. aeruginosa (44 isolates, 5.7%), and Enterobacterium spp. (42 isolates, 5.5%). Distinct antimicrobial resistance profiles were observed between different pathogens as well as between bloodstream-derived and other sources of pathogens. The resistant rates of A. baumanii and P. aeruginosa to antimicrobial agents have been increasing during the most recent 10 years at our hospital. CONCLUSIONS Our data demonstrated the characteristics of nosocomial infections and antibiotic resistance in regional China. The distinct resistance profile of each pathogen can help to tailor individual antimicrobial strategy. The emerging resistant rates to antimicrobials require reinforced actions for infection prevention and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.